BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8865265)

  • 21. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK; Sodhi RK; Singh M
    Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-angiotensin system inhibitors as antihypertrophic agents.
    Ianosi-Irimie M; Deutsch P
    Pharmazie; 2000 Aug; 55(8):629. PubMed ID: 10989849
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of drugs affecting the renin-angiotensin system on venous thrombosis in normotensive rats.
    Chabielska E; Pawlak R; Buczko W
    Pol J Pharmacol; 1996; 48(1):89-91. PubMed ID: 9112634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC; Timmermans PB
    Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cough as secondary effect of ACE inhibitors].
    Albert Cuñat V; Maestro Castelblanque E
    Rev Clin Esp; 1991 Nov; 189(7):345-6. PubMed ID: 1767097
    [No Abstract]   [Full Text] [Related]  

  • 27. Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Abouljoud M; Escobar F; Mozes M
    Transplant Proc; 1997; 29(1-2):207-8. PubMed ID: 9122965
    [No Abstract]   [Full Text] [Related]  

  • 28. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
    He YM; Feng L; Huo DM; Yang ZH; Liao YH
    Nephrology (Carlton); 2013 Sep; 18(9):605-14. PubMed ID: 23869492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angioedema of the intestine.
    Gabb GM
    N Engl J Med; 1996 Nov; 335(20):1534-5; author reply 1535. PubMed ID: 8927095
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bronchospasm and cough connected to Losartan].
    Lakartidningen; 1995 Oct; 92(42):3920. PubMed ID: 7564660
    [No Abstract]   [Full Text] [Related]  

  • 31. Trumping the ACE.
    Vane J
    Lancet; 1995 Sep; 346(8979):916. PubMed ID: 7564719
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference.
    Bangalore S; Kumar S; Messerli FH
    Am J Med; 2010 Nov; 123(11):1016-30. PubMed ID: 21035591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Losartan in post-transplant erythrocytosis.
    Conlon PJ; Smith SR; Butterly DW; Brennan DC
    Nephrol Dial Transplant; 1996 Dec; 11(12):2524-5. PubMed ID: 9017645
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cough induced by converting enzyme inhibitors].
    Ostermann G; Freneaux E; Germain ML; Pasqual JC; Chousy H
    Therapie; 1986; 41(5):404-5. PubMed ID: 3027912
    [No Abstract]   [Full Text] [Related]  

  • 35. Cough and wheeze caused by inhibitors of angiotensin-converting enzyme.
    Semple PF; Herd GW
    N Engl J Med; 1986 Jan; 314(1):61. PubMed ID: 2999601
    [No Abstract]   [Full Text] [Related]  

  • 36. [Autacoids and their role in the pathogenesis of cough induction by angiotension converting enzyme inhibitor].
    Rosendorff C; Knapp C
    Cardiology; 1993; 82 Suppl 2():66-71. PubMed ID: 8100188
    [No Abstract]   [Full Text] [Related]  

  • 37. Reproducibility of angiotensin converting enzyme inhibitor induced cough: a double-blind randomised study.
    Charlon V; Dollow S; Fidel J; Hoglund C; Honkanen T; Kobrin I; McEwan J; McInnes G; Viskoper JR; Woo KS
    Br J Clin Pharmacol; 1995 Feb; 39(2):125-9. PubMed ID: 7742149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cough is common in children prescribed converting enzyme inhibitors.
    von Vigier RO; Mozzettini S; Truttmann AC; Meregalli P; Ramelli GP; Bianchetti MG
    Nephron; 2000 Jan; 84(1):98. PubMed ID: 10644922
    [No Abstract]   [Full Text] [Related]  

  • 39. Difference in the incidence of cough induced by angiotensin converting enzyme inhibitors: a comparative study using imidapril hydrochloride and enalapril maleate.
    Saruta T; Arakawa K; Iimura O; Abe K; Matsuoka H; Nakano T; Nakagawa M; Ogihara T; Kajiyama G; Hiwada K; Fujishima M; Nakajima M
    Hypertens Res; 1999 Sep; 22(3):197-202. PubMed ID: 10515442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cough and inhibitors of the angiotensin-converting enzyme].
    De Groote P; Millaire A; Aisenfarb JC; Marquand A; Ducloux G
    Ann Cardiol Angeiol (Paris); 1988 May; 37(5):251-3. PubMed ID: 3408197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.